1. Introduction {#sec1-jcm-09-01196}
===============

The current outbreak of COVID-19 caused by a new coronavirus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) \[[@B1-jcm-09-01196]\] was located for the first time in Wuhan (China) in December 2019. The symptoms associated with COVID-19 include fever, cough, shortness of breath, diarrhea, and fatigue. Complications include pneumonia, acute severe respiratory distress syndrome, renal insufficiency, or even death in certain cases \[[@B1-jcm-09-01196],[@B2-jcm-09-01196]\].

The rapid spread of the disease, which was already observed during the months of December 2019 and January 2020, led the World Health Organization to define COVID-19 as a global public health emergency on January 30, 2020 \[[@B3-jcm-09-01196]\]. There is a strong probability that the coronavirus that causes this disease, known as SARS-CoV-2, has a zoonotic origin. If this hypothesis is confirmed, veterinarian coronavirologists could be a reference for treatment of infections by SARS-CoV-2 in humans \[[@B4-jcm-09-01196]\]. At the time of writing, March 2020, the high number of cases and the many countries affected define COVID-19 as a global pandemic such that on April 19, 2020 \[[@B5-jcm-09-01196]\] figures related to COVID-19 had surpassed 2,281,714 confirmed cases and over 159,511 deaths associated with COVID-19 on five continents. These data show how highly infectious the SARS-CoV-2 virus, which causes COVID-19, is around the world. The shortage of resources that turns this situation into a worldwide healthcare and social emergency demands the effective combined effort from everyone and of all the organizations involved \[[@B6-jcm-09-01196],[@B7-jcm-09-01196]\]. Neither should it be forgotten that the search for an effective treatment, which is not yet available, requires coordination without precedent of healthcare professionals and the scientific community \[[@B8-jcm-09-01196]\].

Although many clinical studies are underway, those analyzing the impact on psychological well-being of the population are not as numerous \[[@B9-jcm-09-01196]\]. In previous pandemics, studies showed that healthcare professionals were under strong stress from fear of becoming ill, spreading the disease to their families, and the heavy work load \[[@B10-jcm-09-01196],[@B11-jcm-09-01196]\]. Several authors have found that perceived threat of the disease can cause severe psychological maladjustment, such as depression, anxiety and stress \[[@B9-jcm-09-01196],[@B11-jcm-09-01196],[@B12-jcm-09-01196]\], which are involved in the emotional exhaustion of healthcare employees \[[@B13-jcm-09-01196],[@B14-jcm-09-01196]\]. Keeping in mind the importance of perception or representation of the disease in situations of social alert, our study attempted to validate an instrument for measuring the psychological processing of the disease caused by the coronavirus (COVID-19).

Perceived Threat from COVID-19
------------------------------

The disease perception model focuses on the perceptions, constructions, or representations one has about experience with a disease, its identity, consequences, treatment, causes, duration, and cure \[[@B15-jcm-09-01196],[@B16-jcm-09-01196],[@B17-jcm-09-01196]\]. This conception of a disease influences one's interpretation of the symptoms and is conditioned by experience with previous pathologies, as well as by the social and cultural context \[[@B18-jcm-09-01196],[@B19-jcm-09-01196],[@B20-jcm-09-01196]\]. Quiceno and Vinaccia \[[@B21-jcm-09-01196]\] showed that representation of a disease influences prevention behavior, reactions to the symptoms, adherence to treatment when diagnosed, and future expectations for health.

Therefore, one's perception of a disease depends on interpretation of experience, transfer of this interpretation to active behavior, response to social reactions, and personal meaning attributed to the experience. In the situation of imminent alarm in which global society is now immersed with the arrival of COVID-19 and its effect on health, adult perception of the disease acquires considerable significance, as the measures taken by governments involve changes in habits and lifestyles.

The instruments employed in evaluating the perception of disease as a threat may be differentiated by their theoretical foundations \[[@B15-jcm-09-01196],[@B19-jcm-09-01196],[@B20-jcm-09-01196]\]. The scale most widely used is the Illness Perception Questionnaire (IPQ), validated with a sample of patients with chronic diseases (asthma, liver, and diabetes), is made up of 38 items. The nine-item brief version (BIP-Q) \[[@B16-jcm-09-01196]\], has also been widely used \[[@B12-jcm-09-01196],[@B22-jcm-09-01196],[@B23-jcm-09-01196]\]. The original questionnaire measures identity, cause, timeline, consequences, and control/cure. Studies have proven the usefulness of both the original version and the brief questionnaire for exploring perception of the disease in different areas of health \[[@B12-jcm-09-01196],[@B16-jcm-09-01196],[@B23-jcm-09-01196],[@B24-jcm-09-01196]\]. Later, Moss-Morris et al. \[[@B17-jcm-09-01196]\] revised the original questionnaire to extend it to the cognitive and affective dimensions of disease perception in the Illness Perception Questionnaire Revised (IPQ-R) with 70 items. In this version, the "timeline" subscale enables differentiation between acute/chronic and episodic and the "control/cure" subscale between personal control/cure and what can be attributable to the treatment. The authors further added two new subscales which evaluate "emotional representation" on one hand and "coherence" on the other.

Leventhal et al. \[[@B25-jcm-09-01196],[@B26-jcm-09-01196]\] based illness perception on the Common Sense Self-Regulation Model (CSM), which emphasizes empowering the individual with behavior control. From this approach, the perception of illness involves several different processes which explain: 1) how people perceive a threat to their health; 2) how they generate a mental representation and associated emotions with that threat; and 3) how they start up different plans of action for their regulation and coping, which they constantly revised based on feedback received on their efficacy and the progression of the threat.

In view of the relevance of measuring and evaluating the perception of threat from COVID-19 in the population, this study validated the Brief Illness Perception Questionnaire version BIP-Q5 \[[@B20-jcm-09-01196]\] employed, in this case, to evaluate perceived threat from COVID-19.

2. Method {#sec2-jcm-09-01196}
=========

2.1. Participants {#sec2dot1-jcm-09-01196}
-----------------

The sample was made up of 1043 Spanish adults from 19 autonomous regions. The questionnaire had control questions for detecting random or incongruent answers leading to the elimination of 29 subjects, so that the final sample was comprised of 1014 persons of whom 67.2% (*n* = 681) were women and 32.8% (*n* = 333) men, with a mean age of 39.88 (standard deviation (SD) = 12.35) and 42.92 years (SD = 12.33), respectively. The mean sample age was 40.87 (SD = 12.42) ranging from 18 to 76.

2.2. Instruments {#sec2dot2-jcm-09-01196}
----------------

The Brief Illness Perception Questionnaire, version BIP-Q5 \[[@B16-jcm-09-01196]\], made up of nine items and translated into Spanish by Pacheco-Huergo et al. \[[@B27-jcm-09-01196]\], was used in this study. In this shorter version of the BIP-Q, Items 3, 4, and 7 were eliminated, and Item 9 was an open-ended question. The BIP-Q5 therefore consists of five items on perception of threat from illness, where participants rate their agreement with the statements on a Likert-type scale from 0 to 10. The test provides an overall score on the representation of the illness. The higher the score is, the greater the perception of the illness as a threat. This brief version of the questionnaire has adequate psychometric properties \[[@B24-jcm-09-01196]\]. The BIP-Q has also shown acceptable reliability indices with large-scale adult populations in several different countries \[[@B16-jcm-09-01196],[@B23-jcm-09-01196],[@B28-jcm-09-01196],[@B29-jcm-09-01196]\]. Other versions of the questionnaire have robust validations with Spanish samples \[[@B15-jcm-09-01196],[@B30-jcm-09-01196]\]. In this study, the internal consistency coefficient was acceptable with a Cronbach alpha of 0.663. This study is a pioneer in exploration of the psychometric properties of the instrument for COVID-19 in a general adult Spanish population. The BIP-Q5 was therefore adapted to this disease (for example, "How much are you worried about being infected by the coronavirus (COVID-19)?" or "How much does infection by the coronavirus (COVID-19) affect you emotionally?" (That is, does it make you feel furious, afraid, angry or depressed?)".

2.3. Procedure {#sec2dot3-jcm-09-01196}
--------------

This cross-sectional study was carried out in a sample found by snowball sampling, which was publicized on social networks and by texting during the first week of confinement of the Spanish population from March 18 to 23, 2020. The participants filled out the tests individually in an estimated mean time of 5 to 10 minutes. In all cases, ethical research standards were complied with by providing information on the project and requesting consent to participate. The study was approved by the University of Almeria Bioethics Committee (Favorably reported on March 24, 2020).

2.4. Data Analysis {#sec2dot4-jcm-09-01196}
------------------

Data analyses were performed in two stages following the validation steps by Pérez-Fuentes et al. \[[@B31-jcm-09-01196]\]. In the first stage, the BIP-Q5 structure was studied. For this purpose, the sample was divided at random into two independent homogeneous subsamples. The first (*n* = 505) was used as the calibration sample for confirmatory factor analyses (CFA) of the original Threat Perception model. The confirmatory factor analysis for the original model used the following fit indices as measures: χ2/df, comparative fit index (CFI), Tucker-Lewis index (TLI), and root mean square error of approximation (RMSEA) with a confidence interval (CI) of 90%. For the χ2/df, values below five were considered acceptable \[[@B32-jcm-09-01196]\]; for the CFI and incremental fit index (IFI), a value over or near 0.90 were acceptable; and for the RMSEA values below or very near 0.08 were considered acceptable \[[@B33-jcm-09-01196]\]. As a general rule, good fit of the model would be when: 2/DF ≤ 3; TLI \> 0.90; CFI \> 0.95; and RMSEA ≤ 0.05. The appropriate respecifications were made to the model proposed, which had shown good fit indices, considering theoretical and statistical criteria (change indices, errors of estimation, standard errors of measurement), but it did not improve the original model. The Akaike information criterion \[[@B34-jcm-09-01196]\] was used for model selection. The second subsample (*n* = 508) was used as the validation sample for the respecified model. The Cronbach's alpha \[[@B35-jcm-09-01196]\], Spearman--Brown formula, and intraclass correlation coefficient were used for the reliability analysis of the new scale.

Finally, in the second stage, an analysis was performed to find out whether the factor structure was invariant across sex (male/female). In the first place, goodness of fit of these structures was tested separately in both subsamples (Models M0a-Male and Model M0b-Female). The resulting four nested models were evaluated: (a) Model 1, both subsamples were considered together with free estimation of the parameters; (b) Model 2, metric invariance is shown; (c) Model 3, shows scalar invariance; and (d) Model 4, strict invariance. There was no criterion of consensus for determining the criteria to be used to evaluate the difference in fit between the different nested models \[[@B36-jcm-09-01196]\]. The ΔCFI was used for evaluating fit. The model was interpreted as completely invariant if the ΔCFI was below 0.01 \[[@B37-jcm-09-01196]\].

The analyses were performed with the SPSS statistical package version 23.0 for Windows and the AMOS 22 program.

3. Results {#sec3-jcm-09-01196}
==========

3.1. Preliminary Analyses {#sec3dot1-jcm-09-01196}
-------------------------

In the first place, the data showed that the distribution of the items on the BIP-Q5 were within the limits of normality according to the Finney y DiStefano \[[@B38-jcm-09-01196]\] criterion, in which 2 and 7 are the maximum permissible values for skewness and kurtosis, with maximums in our case of 2.1 and 3.8, respectively. In the exploratory factor analysis, principal components extraction was used with direct Oblimin rotation (Kaiser-Meyer-Olkin; KMO = 0.71) which enabled correlation between factors. [Table 1](#jcm-09-01196-t001){ref-type="table"} shows descriptive statistics of the calibration sample (*n* = 505).

3.2. Exploratory Factor Analysis of the Original BIP-Q5 Model {#sec3dot2-jcm-09-01196}
-------------------------------------------------------------

The principal components analysis revealed the existence of one component with eigenvalues over 1. The scree plot showed no need for rotation with only one factor ([Figure 1](#jcm-09-01196-f001){ref-type="fig"}). Thus, in [Table 2](#jcm-09-01196-t002){ref-type="table"} only one component is presented, and that factor (perception of threat from COVID-19) was comprised of five items, all of them with weights over 0.60, except for Item 3 "How much do you feel symptoms of infection by coronavirus?", and these explain 43.87% of the variance.

3.3. Confirmatory Factor Analysis of the BIP-Q5 Model for COVID-19 {#sec3dot3-jcm-09-01196}
------------------------------------------------------------------

Fit of the questionnaire models is presented in [Table 3](#jcm-09-01196-t003){ref-type="table"} according to the original BIP-Q5 model (analyzing the one-factor and two-factor models of the BIP-Q5), adapted to COVID-19.

Although both the one-factor and two-factor versions of the original model showed adequate values, they could be improved. The one-factor model of the BIP-Q5, which consisted of a single factor and five items, was the most adequate once some respecifications had been analyzed considering theoretical and statistical criteria (change indices, errors of estimation, standard errors of measurement). The one-factor model of the BIP-Q5 then had a much better fit with the calibration sample. In addition, as the difference between the Akaike Information Criterion (AIC) default model = 40,167 and the AIC saturated model = 49,000 was very small, it is probably the best according to the Akaike criteria for model selection ([Figure 2](#jcm-09-01196-f002){ref-type="fig"}).

Finally, data from confirmatory factor analysis of the model proposed with the validation sample (*n* = 508) showed the following fit indices: *χ^2^/df =* 3.081, CFI = 0.973, TLI = 0.947, and RMSEA = 0.064 (0.029--0.102), which are adequate values.

The reliability analysis of the model yielded a Spearman--Brown coefficient of *p* = 0.65 and Cronbach's alpha with the whole sample was α = 0.66. The temporal stability analysis yielded an intraclass correlation coefficient (ICC) for perception of threat from COVID-19 of 65 and confidence interval = 0.62--0.69.

[Table 4](#jcm-09-01196-t004){ref-type="table"} shows the values for the six different models in the analysis of variance by sex, where it may be seen that in practically all cases, the ΔCFI was below 0.01, therefore configural, metric, and strict invariance may be accepted. Strong invariance may not be assumed, since the factor coefficients and intercepts for the two models evaluated were not equivalent.

[Table 5](#jcm-09-01196-t005){ref-type="table"} includes the scales evaluating the level of threat in the Spanish population, and also by sex.

4. Discussion {#sec4-jcm-09-01196}
=============

This study was performed to adapt the BIP-Q5 questionnaire to the disease caused by the SARS-CoV-2 (COVID-19), and to acquire more information on the instrument's factor structure and test reliability and validity for this disease in a sample of Spanish adults.

The analyses performed revealed that the fit of the one-factor model of the BIP-Q5 was better than the two-factor model, showing the validity of the unidimensional model for evaluating the perception of threat from COVID-19. This result coincides with previous studies that have tested the validity and reliability of the BIP-Q5 in an adolescent Spanish population \[[@B24-jcm-09-01196]\], and also with a larger number of studies done with adult populations in other countries using the brief version of the IPQ (BIP-Q) \[[@B22-jcm-09-01196]\]. However, although correlations between residuals in the model enabled us to identify opportunities for improving the instrument, (mainly Item 3 since it was below 0.60 on most of the items on the questionnaire i.e., Items 1, 2, 4, and 5), the test--retest values were optimum, explaining the total for the scale of 43.87 of the variance in perception of the disease. Compared to the study by Valero-Moreno et al. \[[@B24-jcm-09-01196]\], internal consistency of the Spanish version adapted to COVID-19 found with the Cronbach's alpha coefficient was acceptable, but somewhat lower.

Some limitations of this study should be mentioned. Although this brief version of the IPQ can quickly evaluate perception of disease, in our case adapted to COVID-19, and it is useful in studies operating with large samples, it should be proven and validated in other cultures, where its validity has already been demonstrated for other diseases. Furthermore, during data acquisition, although self-report scales are commonly used in research, there may have been some associated social desirability biases. Another of the limitations is the sex distribution of the sample, which could be due to the sampling procedure, but keeping in mind the general characteristic of the Spanish population in this respect, it may be considered representative as there are also more women than men in the population. The research design was a cross-sectional study which did not allow some factors that may have affected participant response to be controlled for, such as access to communication media, local number of cases in the city where the participant resides, time when surveyed, past experience with pandemics, level of preparation, available social and family support, cultural context, and religious beliefs. Future studies could add information on the relationship of these variables to perception of COVID-19.

5. Conclusions {#sec5-jcm-09-01196}
==============

This study intended to examine the representation of COVID-19 disease in the Spanish culture using a version of the BIP-Q5 adapted to its perception. The exploratory and confirmatory factor analyses supported a one-factor model with five items which, in the set of analyses performed, was the one that showed the best psychometric properties. Internal consistency for the overall scale was acceptable. This brief version of the IPQ supported the factor structure of the test for measuring perception of threat of COVID-19, produced by the SARS-CoV-2 virus in an adult Spanish population. These findings are pioneer for this disease and can orient preventive intervention that enables psychological wellbeing and quality of life to be improved in situations similar to the pandemic.
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jcm-09-01196-t001_Table 1

###### 

Descriptive statistics. Calibration sample (*n* = 505).

  Items      *n*   M      SD     Skewness   Kurtosis           
  ---------- ----- ------ ------ ---------- ---------- ------- ------
  BIP-Q5 1   505   7.66   2.11   −1.27      0.11       1.75    0.22
  BIP-Q5 2   505   6.95   1.68   −0.65      0.11       0.61    0.22
  BIP-Q5 3   505   2.02   1.86   2.1        0.11       3.8     0.22
  BIP-Q5 4   505   7.75   2.17   −1.02      0.11       0.48    0.22
  BIP-Q5 5   505   6.61   2.39   −0.51      0.11       −0.52   0.22

Note: BIP-Q5 = Brief Illness Perception Questionnaire; SD: standard deviation.

jcm-09-01196-t002_Table 2

###### 

Factor structure, communalities (h^2^) eigenvalues, Cronbach's alpha and percentage of explained variance (*n* = 505). Extraction method: principal components factoring.

                                  F1                               *h*2
  ------------------------------- -------------------------------- -------
  Item 1                          0.618                            0.383
  Item 2                          0.607                            0.369
  Item 3                          0.314                            0.099
  Item 4                          0.817                            0.667
  Item 5                          0.822                            0.676
  Percentage explained variance   43.87                            
  Kaiser--Meyer--Olkin            0.71                             
  Barlett's sphericity            χ2(10) = 426.320, *p* \< 0.000   
  Cronbach's alpha                0.663                            

jcm-09-01196-t003_Table 3

###### 

Fit indices for the models proposed (calibration sample *n* = 505).

  Model                                               CFI     TLI     RMSEA           
  -------------------------------- ----------- ------ ------- ------- ------- ------- -------
  One-factor model of the BIP-Q5   10.2 (5)    2.1    0.988   0.975   0.045   0.000   0.085
  Two-factor model of the BIP-Q5   9.999 (4)   2.49   0.986   0.964   0.055   0.010   0.098

Note: CFI = comparative fit index; TLI = Tucker--Lewis index; RMSEA = root mean square error of approximation; CI = confidence interval; *df* = degrees of freedom.

jcm-09-01196-t004_Table 4

###### 

Multigroup invariance by sex (male/female).

  -----------------------------------------------------------------------------------------------------------
  Model                 χ2              df   χ2 / df   Δχ2     CFI     ΔCFI    IFI     RMSEA (CI 90%)
  --------------------- --------------- ---- --------- ------- ------- ------- ------- ----------------------
  M0a (male)            29.129\         10   2.912             0.976           0.976   0.044 (0.026--0.063)
                        (*p* = 0.001)                                                  

  M0b (female)          29.129\         10   2.912             0.976           0.976   0.044 (0.026--0.063)
                        (*p* = 0.001)                                                  

  M1 (base model set)   29.129\         10   2.912             0.976           0.976   0.044 (0.026--0.063)
                        (*p* = 0.001)                                                  

  M2 (FS)               34.822\         14   2.487     0.424   0.973   0.003   0.974   0.039 (0.023--0.055)
                        (*p* = 0.002)                                                  

  M3 (FS + Int)         65.620\         19   3.453     0.966   0.940   0.033   0.940   0.050 (0.037--0.063)
                        (*p* = 0.000)                                                  

  M4 (FS + Int + Err)   76.002\         25   3.041     0.412   0.935   0.005   0.934   0.045 (0.034--0.057)
                        (*p* = 0.000)                                                  
  -----------------------------------------------------------------------------------------------------------

Note: FS = factor saturations, Int = intercepts, Err = errors.

jcm-09-01196-t005_Table 5

###### 

Scales for general population and by sex.

                           General   Male    Female
  ----------------- ------ --------- ------- --------
                    M      30.74     29.22   31.48
                    *S*D   6.63      7.03    6.29
                    Min    8         8       11
                    Max.   50        50      48
  **Percentiles**   10     21        20      23
                    20     25        23      26
                    30     28        27      29
                    40     30        28      30
                    50     31.5      30      32
                    60     33        32      34
                    70     34        33      35
                    80     36        35      37
                    90     38        37      39
                    95     40        39      41
                    99     45        43.66   45
